GRTHO:BISTGrainturk Holding A.S. Analysis
Data as of 2026-06-14 - not real-time
TRY 232.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
GRTHO is trading at 232 TRY, comfortably above its 20‑day SMA of 213.19 but still below the 50‑day SMA of 234.75, signaling mixed short‑term momentum. The MACD histogram has turned positive (≈2.99) while the MACD line sits above its signal, a bullish cue that aligns with the recent increase in volume. RSI at 55.9 suggests the stock is neither overbought nor oversold. However, the overall trend is flagged as bearish and the 30‑day volatility is extreme at 57%, implying large price swings. Beta is exceptionally low at 0.09, so market‑wide moves have limited impact on GRTHO. Support sits near 199.9 TRY and resistance near 243 TRY, framing the current price within a relatively tight range.
Fundamentally, the company posted a 2.5% revenue decline and a negative free‑cash‑flow of –1.19 bn TRY, raising concerns about cash generation. Debt‑to‑equity is alarming at 9.0, though the balance sheet shows more cash (1.84 bn TRY) than debt (0.91 bn TRY). Profit margins are solid (26% net margin) and ROE stands at 22.5%, indicating efficient core operations. Valuation metrics are out of line: the DCF‑derived fair value of ~66 TRY is less than one‑third of the market price, and the price‑to‑book of 3.2 further signals overvaluation. Dividend yield is a modest 0.39% with a zero payout ratio, making dividend sustainability doubtful. Combined with high volatility, heavy leverage, and a bearish macro environment in Turkey, the stock carries a medium‑to‑high risk profile.
Fundamentally, the company posted a 2.5% revenue decline and a negative free‑cash‑flow of –1.19 bn TRY, raising concerns about cash generation. Debt‑to‑equity is alarming at 9.0, though the balance sheet shows more cash (1.84 bn TRY) than debt (0.91 bn TRY). Profit margins are solid (26% net margin) and ROE stands at 22.5%, indicating efficient core operations. Valuation metrics are out of line: the DCF‑derived fair value of ~66 TRY is less than one‑third of the market price, and the price‑to‑book of 3.2 further signals overvaluation. Dividend yield is a modest 0.39% with a zero payout ratio, making dividend sustainability doubtful. Combined with high volatility, heavy leverage, and a bearish macro environment in Turkey, the stock carries a medium‑to‑high risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price above 20‑day SMA but below 50‑day SMA indicating bearish bias
- positive MACD histogram and rising volume suggest short‑term upside
- extreme 30‑day volatility and overvaluation caution against aggressive buying
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value (~66 TRY) far below market price (~232 TRY)
- declining revenue and negative free cash flow undermine growth prospects
- high leverage (Debt/Equity ~9) increases financial risk
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- stable profit margins and strong ROE indicate resilient core business
- very low beta reduces systematic market risk
- exposure to Turkish macro‑economic and currency volatility remains a concern
Key Metrics & Analysis
Financial Health
Revenue Growth-2.50%
Profit Margin26.27%
P/E Ratio16.2
ROE22.55%
ROA4.82%
Debt/Equity9.03
P/B Ratio3.2
Op. Cash FlowTRY797.6M
Free Cash FlowTRY-1188808832
Technical Analysis
TrendBearish
RSI55.9
SupportTRY 199.90
ResistanceTRY 243.00
MA 20TRY 213.19
MA 50TRY 234.75
MA 200TRY 317.12
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueTRY 66.55
GradeOvervalued
TypeValue
Dividend Yield0.39%
Risk Assessment
Beta0.09
Volatility57.28%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.